Site icon Fintech Advance

IAC Stock: An Asymmetric Bet With Shareholder-Friendly Capital Allocation In Play (IAC)

This article was written by

Being the Financial Manager of SmileWise, an incubator and accelerator of healthcare businesses, I see major changes on the horizon. The company is specialized in digital marketing, strategic advice and financing. Before joining SmileWise in 2019, I worked as a financial advisor for Deutsche Bank and as marketeer for a European financial technology start-up. As a trained macro-economist with a major in International Economics (Ghent University), I take a holistic and global approach to the stock market. I also hold an MBA from the Vlerick Business School (#1 in the Benelux). Having been involved in private company valuations, M&A discussions and laying the financial foundations for new business to get funded, I am well-equipped to write about innovative healthcare companies, especially when technology is involved. Favoring big margins of safety, I usually build prudent financial models.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of IAC, ZD either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Read the full article here

Exit mobile version